You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Presenilin 1 antibody (ab7297)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Presenilin 1 antibody
See all Presenilin 1 products (20) ...

Description

Goat polyclonal to Presenilin 1

Tested applications

ELISA, WB, IHC-P, IHC-Frmore details

Cross reactivity

Reacts with

Human

Immunogen

Synthetic peptide, corresponding to amino acids 14-33 of Human Presenilin 1.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: None
Constituents: Whole Serum

Purity

Whole antiserum

Clonality

Polyclonal

Isotype

IgG

Applications

Show applications key

Our Abpromise guarantee covers the use of ab7297 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • ELISA

     ELISA: 1/5000

    ELISA: 1/5000

  • ShowHide

    WB

     WB: Use at an assay depe...Read more →

    WB: Use at an assay dependent dilution. Predicted molecular weight: 48 kDa.

  • ShowHide

    IHC-P

     IHC-P: 1/100Antigen retr...Read more →

    IHC-P: 1/100Antigen retrieval is not essential but may optimise staining.

  • IHC-Fr

     IHC-Fr: 1/100

    IHC-Fr: 1/100

Target

Function

Probable catalytic subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (beta-amyloid precursor protein). Requires the other members of the gamma-secretase complex to have a protease activity. May play a role in intracellular signaling and gene expression or in linking chromatin to the nuclear membrane. Stimulates cell-cell adhesion though its association with the E-cadherin/catenin complex. Under conditions of apoptosis or calcium influx, cleaves E-cadherin promoting the disassembly of the E-cadherin/catenin complex and increasing the pool of cytoplasmic beta-catenin, thus negatively regulating Wnt signaling. May also play a role in hematopoiesis.

Tissue specificity

Expressed in a wide range of tissues including various regions of the brain, liver, spleen and lymph nodes.

Involvement in disease

Defects in PSEN1 are a cause of Alzheimer disease type 3 (AD3) [MIM:607822]. AD3 is a familial early-onset form of Alzheimer disease. Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituent of these plaques is the neurotoxic amyloid-beta-APP 40-42 peptide (s), derived proteolytically from the transmembrane precursor protein APP by sequential secretase processing. The cytotoxic C-terminal fragments (CTFs) and the caspase-cleaved products such as C31 derived from APP, are also implicated in neuronal death.
Defects in PSEN1 are a cause of frontotemporal dementia [MIM:600274].
Defects in PSEN1 are the cause of cardiomyopathy dilated type 1U (CMD1U) [MIM:613694]. It is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.
Defects in PSEN1 are the cause of acne inversa familial type 3 (ACNIF3) [MIM:613737]. A chronic relapsing inflammatory disease of the hair follicles characterized by recurrent draining sinuses, painful skin abscesses, and disfiguring scars. Manifestations typically appear after puberty.

Sequence similarities

Belongs to the peptidase A22A family.

Domain

The PAL motif is required for normal active site conformation.

Post-translational
modifications

Heterogeneous proteolytic processing generates N-terminal (NTF) and C-terminal (CTF) fragments of approximately 35 and 20 kDa, respectively. During apoptosis, the C-terminal fragment (CTF) is further cleaved by caspase-3 to produce the fragment, PS1-CTF12.
After endoproteolysis, the C-terminal fragment (CTF) is phosphorylated on serine residues by PKA and/or PKC. Phosphorylation on Ser-346 inhibits endoproteolysis.

Cellular localization

Endoplasmic reticulum membrane. Golgi apparatus membrane. Cell surface. Bound to NOTCH1 also at the cell surface. Colocalizes with CDH1/2 at sites of cell-cell contact. Colocalizes with CTNNB1 in the endoplasmic reticulum and the proximity of the plasma membrane. Also present in azurophil granules of neutrophils.

Target information above from: UniProt accessionP49768 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • AD 3 antibody
  • AD3 antibody
  • Ad3h antibody
  • Alzheimer Disease 3 antibody
  • FAD antibody
  • FAD antibody
  • Homo Sapiens Clone CC44 Senilin 1 antibody
  • Presenilin-1 CTF12 antibody
  • Presenilin1 antibody
  • Protein S182 antibody
  • PS 1 antibody
  • PS-1 antibody
  • PS1 antibody
  • PS1-CTF12 antibody
  • PSEN 1 antibody
  • PSEN1 antibody
  • PSN1_HUMAN antibody
  • PSNL 1 antibody
  • PSNL1 antibody
  • S182 antibody
  • S182 Protein antibody
  • Senilin 1 antibody
see all

References for Anti-Presenilin 1 antibody (ab7297)

ab7297 has not yet been referenced specifically in any publications.

Publishing research using ab7297? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"